The latest published report by Polaris Market Research The report “Circulating Tumor Cells Market Share, Size, Trends, Industry Analysis Report, By Technology (CTC Detection & Enrichment Methods, CTC Direct Detection Methods, CTC Analysis); By Application (Clinical/Liquid Biopsy, Research); By Product; By Specimen; By Region; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The global circulating tumor cells market was valued at USD 9.81 billion in 2020 and size is expected to reach USD 26.45 Billion by 2028 during the forecast period [2021 – 2028]. Circulating tumor cells obtained via liquid biopsies are safer, cheaper, and less invasive than other surgical biopsies as liquid biopsies are considered a valuable tool in cancer diagnosis, before and after the onset of disease. Though circulating tumor cells technology is still under research phase but used for the prognosis of several cancer forms including, breast, melanoma, lung, colon, pancreas, and glioblastoma.
In the future, doctors would have a better chance of fighting cancer via liquid biopsies, and researchers would detect circulating tumor cells before any metastatic growth happens. Currently, circulating tumor cell-based screening and analysis are at a nascent market stage. The market dominance of cell-free DNA units over circulating tumor cells in cancer diagnosis has led to less share in clinical applications. The presence of circulating tumor cells in the bloodstream indicates a risk of metastasis and emergence of tumors.
Companies operating in the market of circulating tumor cells such as Greiner Bio-One; BioFluidica, QIAGEN; Bio-Techne Corporation; Rarecells Diagnostics, ScreenCell, Menarini Silicon Biosystems; Fluxion Biosciences, Sysmex Corporation; Miltenyi Biotec, and Biocept, Inc.
In Latin America, the market is expected to garner the fastest growth over the forecast period. The regional market growth is attributed to growing awareness regarding the benefits of conducting such type of testing, well-established healthcare infrastructure, and rapidly increasing geriatric population in the region. In addition to this, increasing demand for preventive medicine is turning out as a major booster for the regional market. The Asia Pacific followed by Europe is projected to continue dominating the circulating tumor cells testing market as a result of the rise in demand for better healthcare services, government efforts to reduce the incidences of disease, and increasing investment by public-private organizations to improve the overall healthcare services.
Have Any Query Or Specific Requirement? Feel Free to Ask Our Industry Experts at: https://www.polarismarketresearch.com/industry-analysis/circulating-tumor-cells-market/speak-to-analyst
Owing to the advantages and non-invasiveness of CTCs, the market companies and concerned academic institutions are undertaking several strategic initiatives to expand of CTCs in clinical facilities. In this direction, in October 2019, Bioloidics collaborated with Genome Institute of Singapore to develop a circulating tumor assay using the company’s in-proprietary ClearCell FX1 technology.
The research market segment is projected to witness a lucrative growth rate over the assessment period. This high market growth is due to the fact that most of the products currently being on the market are primarily designed for research settings. Some of the key products currently in the market include Target Selector Platform, Celsee PREP 400, Parsortix Technology, VTX-1, and IsoFlux CTC system.
Request for Discount Pricing with Your Specific Research Needs At: https://www.polarismarketresearch.com/industry-analysis/circulating-tumor-cells-market/request-for-discount-pricing
Polaris Market Research has segmented the circulating tumor cells market report on the basis of technology, application, product, specimen, and region:
Circulating Tumor Cells, Technology Outlook (Revenue – USD Million, 2016 – 2028)
- CTC Detection & Enrichment Methods
- Immunocapture (Label-based)
- Size-based Separation (Label-free)
- Density-based Separation (Label-free)
- Combined Methods (Label-free)
- CTC Direct Detection Methods
- CTC Analysis
Circulating Tumor Cells, Application Outlook (Revenue – USD Million, 2016 – 2028)
- Clinical/Liquid Biopsy
Circulating Tumor Cells, Product Outlook (Revenue – USD Million, 2016 – 2028)
- Kits & Reagents
- Blood Collection Tubes
- Devices or Systems
Circulating Tumor Cells, Specimen Outlook (Revenue – USD Million, 2016 – 2028)
- Bone Marrow
- Other Body Fluids
Circulating Tumor Cells, Regional Outlook (Revenue – USD Million, 2016 – 2028)
- North America (U.S., Canada)
- Europe (France, Germany, UK, Italy, Spain, Netherlands, Austria)
- Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea)
- Latin America (Brazil, Mexico, Argentina)
- Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)
The report can be customized on the basis of regional analysis, segment analysis, industry outlook and competitive analysis. Some of the major focus points which are covered in the report include:
- Industry Trends, opportunity and challenges in the market
- Role of key players across the value chain
- End-User analysis to define the market strategy
- Competitive mapping
- Regional and country level breakdown
These insights are included in the report which would help you to have a realistic overview of the overall market including the competition, investment opportunities, restraints and challenges, regulatory factors which might affect the market growth. Moreover, the report would help to identify the regional market growth opportunities for different segments covered in the report.
Find more research reports on Healthcare Industry by Polaris Market Research
About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavour to deliver value-added business solutions to our customers.
Polaris Market Research